Shiff Susan Ph.D. has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 12000 shares of Tvardi Therapeutics, Inc. ($TVRD) on April 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 17, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Shiff Susan Ph.D. | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| June 4, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Shiff Susan Ph.D. | Not found | A | Common Stock | 150647 | $0.00 | 202,085.0000 | 1,516,336 | 292.87% | 9.93% |
| June 4, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Shiff Susan Ph.D. | Not found | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 1,516,336 | 9999.99% | 12.86% |
| June 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Shiff Susan Ph.D. | Director | A | Common Stock | 32362 | $0.00 | 51,438.0000 | 53,872,038 | 169.65% | 0.06% |
| June 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Shiff Susan Ph.D. | Director | A | Stock Option (Right to Buy) | 44961 | $0.00 | 44,961.0000 | 53,872,038 | 9999.99% | 0.08% |